Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Amanda Fortes Francisco 
;
Michael D Lewis ;
ShiromaniJayawardhana;
Martin C Taylor ;
EricChatelain;
John M Kelly ;
(2015)
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Antimicrobial agents and chemotherapy, 59 (12).
7925-.
ISSN 0066-4804
DOI: 10.1128/AAC.02022-15
;
Michael D Lewis ;
ShiromaniJayawardhana;
Martin C Taylor ;
EricChatelain;
John M Kelly ;
(2015)
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Antimicrobial agents and chemotherapy, 59 (12).
7925-.
ISSN 0066-4804
DOI: 10.1128/AAC.02022-15
-
picture_as_pdf - aacreply7925.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
Find work associated with the research centre(s):
Find work from this publication:
Find other related resources:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649144 (OA Location)
- 10.1128/AAC.02022-15 (DOI)
- 26578702 (PubMed)